Developmental neurotoxicity of chlorpyrifos: what is the vulnerable period? - PubMed (original) (raw)
Developmental neurotoxicity of chlorpyrifos: what is the vulnerable period?
Dan Qiao et al. Environ Health Perspect. 2002 Nov.
Abstract
Previously, we found that exposure of neonatal rats to chlorpyrifos (CPF) produced brain cell damage and loss, with resultant abnormalities of synaptic development. We used the same biomarkers to examine prenatal CPF treatment so as to define the critical period of vulnerability. One group of pregnant rats received CPF (subcutaneous injections in dimethyl sulfoxide vehicle) on gestational days (GD) 17-20, a peak period of neurogenesis; a second group was treated on GD9-12, the period of neural tube formation. In the GD17-20 group, the threshold for a reduction in maternal weight gain was 5 mg/kg/day; at or below that dose, there was no evidence (GD21) of general fetotoxicity as assessed by the number of fetuses or fetal body and tissue weights. Above the threshold, there was brain sparing (reduced body weight with an increase in brain/body weight ratio) and a targeting of the liver (reduced liver/body weight). Indices of cell packing density (DNA per gram of tissue) and cell number (DNA content) similarly showed effects only on the liver; however, there were significant changes in the protein/DNA ratio, an index of cell size, in fetal brain regions at doses as low as 1 mg/kg, below the threshold for inhibition of fetal brain cholinesterase (2 mg/kg). Indices of cholinergic synaptic development showed significant CPF-induced defects but only at doses above the threshold for cholinesterase inhibition. With earlier CPF treatment (GD9-12), there was no evidence of general fetotoxicity or alterations of brain cell development at doses up to the threshold for maternal toxicity (5 mg/kg), assessed on GD17 and GD21; however, augmentation of cholinergic synaptic markers was detected at doses as low as 1 mg/kg. Compared with previous work on postnatal CPF exposure, the effects seen here required doses closer to the threshold for fetal weight loss; this implies a lower vulnerability in the fetal compared with the neonatal brain. Although delayed neurotoxic effects of prenatal CPF may emerge subsequently in development, our results are consistent with the preferential targeting of late developmental events such as gliogenesis, axonogenesis, and synaptogenesis.
Similar articles
- Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood.
Qiao D, Seidler FJ, Tate CA, Cousins MM, Slotkin TA. Qiao D, et al. Environ Health Perspect. 2003 Apr;111(4):536-44. doi: 10.1289/ehp.5828. Environ Health Perspect. 2003. PMID: 12676612 Free PMC article. - Critical periods for chlorpyrifos-induced developmental neurotoxicity: alterations in adenylyl cyclase signaling in adult rat brain regions after gestational or neonatal exposure.
Meyer A, Seidler FJ, Aldridge JE, Tate CA, Cousins MM, Slotkin TA. Meyer A, et al. Environ Health Perspect. 2004 Mar;112(3):295-301. doi: 10.1289/ehp.6755. Environ Health Perspect. 2004. PMID: 14998743 Free PMC article. - Chlorpyrifos exposure during neurulation: cholinergic synaptic dysfunction and cellular alterations in brain regions at adolescence and adulthood.
Qiao D, Seidler FJ, Abreu-Villaça Y, Tate CA, Cousins MM, Slotkin TA. Qiao D, et al. Brain Res Dev Brain Res. 2004 Jan 31;148(1):43-52. doi: 10.1016/j.devbrainres.2003.10.004. Brain Res Dev Brain Res. 2004. PMID: 14757517 - Developmental cholinotoxicants: nicotine and chlorpyrifos.
Slotkin TA. Slotkin TA. Environ Health Perspect. 1999 Feb;107 Suppl 1(Suppl 1):71-80. doi: 10.1289/ehp.99107s171. Environ Health Perspect. 1999. PMID: 10229709 Free PMC article. Review. - Evaluation of epidemiology and animal data for risk assessment: chlorpyrifos developmental neurobehavioral outcomes.
Li AA, Lowe KA, McIntosh LJ, Mink PJ. Li AA, et al. J Toxicol Environ Health B Crit Rev. 2012;15(2):109-84. doi: 10.1080/10937404.2012.645142. J Toxicol Environ Health B Crit Rev. 2012. PMID: 22401178 Free PMC article. Review.
Cited by
- Correlating agricultural use of organophosphates with outdoor air concentrations: a particular concern for children.
Harnly M, McLaughlin R, Bradman A, Anderson M, Gunier R. Harnly M, et al. Environ Health Perspect. 2005 Sep;113(9):1184-9. doi: 10.1289/ehp.7493. Environ Health Perspect. 2005. PMID: 16140625 Free PMC article. - Fetal chlorpyrifos exposure: adverse effects on brain cell development and cholinergic biomarkers emerge postnatally and continue into adolescence and adulthood.
Qiao D, Seidler FJ, Tate CA, Cousins MM, Slotkin TA. Qiao D, et al. Environ Health Perspect. 2003 Apr;111(4):536-44. doi: 10.1289/ehp.5828. Environ Health Perspect. 2003. PMID: 12676612 Free PMC article. - Developmental neurotoxicity of low dose diazinon exposure of neonatal rats: effects on serotonin systems in adolescence and adulthood.
Slotkin TA, Ryde IT, Levin ED, Seidler FJ. Slotkin TA, et al. Brain Res Bull. 2008 Mar 28;75(5):640-7. doi: 10.1016/j.brainresbull.2007.10.008. Epub 2007 Nov 12. Brain Res Bull. 2008. PMID: 18355640 Free PMC article. - Prenatal dexamethasone augments the sex-selective developmental neurotoxicity of chlorpyrifos: implications for vulnerability after pharmacotherapy for preterm labor.
Slotkin TA, Card J, Infante A, Seidler FJ. Slotkin TA, et al. Neurotoxicol Teratol. 2013 May-Jun;37:1-12. doi: 10.1016/j.ntt.2013.02.002. Epub 2013 Feb 14. Neurotoxicol Teratol. 2013. PMID: 23416428 Free PMC article. - Alterations in central nervous system serotonergic and dopaminergic synaptic activity in adulthood after prenatal or neonatal chlorpyrifos exposure.
Aldridge JE, Meyer A, Seidler FJ, Slotkin TA. Aldridge JE, et al. Environ Health Perspect. 2005 Aug;113(8):1027-31. doi: 10.1289/ehp.7968. Environ Health Perspect. 2005. PMID: 16079074 Free PMC article.
References
- Brain Res Dev Brain Res. 2002 Feb 28;133(2):151-61 - PubMed
- Environ Health Perspect. 1999 Feb;107 Suppl 1:71-80 - PubMed
- Anal Biochem. 1980 Mar 1;102(2):344-52 - PubMed
- Prog Brain Res. 1988;73:335-48 - PubMed
- Pediatr Res. 1988 Nov;24(5):583-7 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources